One trade worth £3,000 at 16.5p/share has pushed up the share price of shell company Pacific Global Holdings (LON: PCH) by 16% to 1.45p. This is the largest trade this year.
Kropz (LON: KRPZ) had a record production month at Elandsfontein in March. There was 40,792 tonnes of phosphate concentrate produced, the previous record was 34,070 tonnes. Fourth quarter production was 115,686 tonnes. Elandsfontein is still in a trial production phase. Management says water-related challenges at the Hinda project should no longer be a significant risk. The share price increased 15.4% to 1.5p.
Wound care provider Advanced Medical Solutions (LON: AMS) has received a bid approach from US private equity firm TA Associates. Healthcare is a major sector for the firm. It has been suggested that the offer could be around 280p/share. The share price is up 14.8% to 261.75p, which is the highest it has been since 2023.
Smart video technology company SEEEN (LON: SEEN) has appointed Zeus as nominated adviser and broker. Christopher Andrews is replacing Mark Williams as independent non-executive director. The share price improved 14.3% to 4p.
West Coast Silver, the joint venture partner of Alien Metals (LON: UFO) in the Elizabeth Hill silver project in Western Australia, has asked for ASX share trading to be halted pending an announcement of a JORC mineral resource estimate for Elizabeth Hill. The Alien Metals share price rose 12% to 0.16p.
Consumer products supplier Supreme (LON: SUP) says trading was better than expected in the year to March 2026. Shore has upgraded its pre-tax profit forecast to £30.7m, down from £32.4m following the banning of disposable vapes. Even so, sales of vapes have held up. Recently acquired SlimFast made a good contribution. Despite spending on acquisitions and a new wellness manufacturing facility, Supreme had net cash at the year end. The 2027 forecasts have not been changed yet, and they will be hit by the UK vaping tax in October. The share price recovered 9.86% to 156p, which is eight times estimated earnings with a forecast yield of around 3%.
FALLERS
Clinical messaging technology developer Feedback (LON: FDBK) continues to talk with the NHS about the deployment of its technology. However, a decision has been delayed until the end of the year or early next year. This means that there will be no significant boost to revenues until next year, although the existing contract with Queen Victoria Hospital in Sussex. Feedback is not renewing its contract with the Royal Berkshire NHS Foundation Trust. There should be enough cash until the middle of 2027. Unsurprisingly, the share price dived 21.9% to 11.25p.
Caledonian Holdings (LON: CHP) is changing its investing policy and plans to consolidate 1,000 shares into one new share on 12 May. Caledonian Holdings intends to acquire financial services and payments company, and this requires the change in investing policy. Aspire will provide an operating and technology platform, which can be used to deploy products of investee companies. The share price slipped 19.5% to 0.0033p.
ECR Minerals (LON: ECR) is acquiring Paleogold for up to A$10.6m. This company owns interests in to exploration and development stage gold projects in Australia. The main interest is a 50% stake in six Maddens Flat mines, which have an estimated mineral resource of 6,322 ounces of gold. That was estimated in 1999 and there is scope to increase it. The mines could be in production within six months after A$1m of investment. There is also a 20% stake in the Salt Bush Flat gold mine, which could have 10,000 ounces of gold. ECR Minerals already has assets near to production. Raglan could be in production within two months. The share price declined 5.45% to 0.26p.